A world eager for progress on vaccines to guard against the SARS-CoV-2 coronavirus and/or COVID-19 might have to wait a bit longer for a breakthrough. The CEO of Moderna(NASDAQ:MRNA), the developer o… [+1394 chars]
Moderna Pulling Back on Coronavirus Vaccine Trial Enrollment to Get More Minority Patients Involved – Motley Fool
